Friday, October, 23, 2009
New Drug For Schizophrenia
February 19, 2009
This is a study to examine how well a new drug for schizophrenia--currently known as AQW051--helps enhance various kinds of brain function in people who have the condition. The study will also assess how well the drug is tolerated and the effects of different doses. This seven-state study is currently recruiting adults ages 18 years to 80 years old who have schizophrenia.
Read more »
Expert & Community Posts
By Christina Bruni
,
Health Expert
...or unusual symptom flares up, as it could be the schizophrenia in a new disguise. The truth is,...
Read more »
By Christina Bruni
,
Health Expert
There's some good news for people diagnosed with schizophrenia. The National Institute on Mental...
Read more »
By Paul Ballas
,
Health Expert
Recently, I was reviewing the literature on tardive dyskinesia, and it struck me how frustrating it...
Read more »
By Jerry Kennard
,
Health Expert
...strategies in the search for some biological basis for schizophrenia is to locate abnormalities...
Read more »
Health Guide
...repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in
schizophrenia: a meta-analysis. J Clin Psychiatry. 2007 Mar;68(3):416-21.Crespo-Facorro B,...
Read more »
CausesNo single cause can account for
schizophrenia. Rather, it appears to be the result of multiple causes such as genetic factors, environmental and psychological assaults, and possible hormonal...
Read more »
...Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment
schizophrenia in teenagers. These drugs are the first atypical antipsychotics approved...
Read more »
Schizophrenia has a devastating effect on all aspects of human thought, emotion, and expression. Only about 20% of patients reach full recovery after a first episode, but new drugs are...
Read more »
Schizophrenia is categorized as a brain disease, not a psychological disorder, and drug treatment is the primary therapy. Studies indicate, however, that an integrated approach better...
Read more »
Related News
October 09, 2008
This is a study to compare the effects of a new drug, paliperidone palmitate, with Risperdal Consta in people who suffer from schizophrenia. This...
Read summary »
November 19, 2008
This is a study to compare the effects of a new drug for schizophrenia (AL-108) to a placebo in people suffering from schizophrenia. Researchers will...
Read summary »
August 28, 2008
(Ivanhoe Newswire) -- Even though there have been safety warnings about antipsychotic drugs among the elderly, a new study shows seniors continue to...
Read summary »
July 30, 2009
Phase III clinical trials on a new drug to treat schizophrenia have been stopped, its makers report. Officials with drugmakers Lundbeck and Solvay...
Read summary »
April 01, 2009
A new schizophrenia treatment that had shown great promise in earlier studies has failed to work better than a currently used medication or a placebo...
Read summary »